Shatshn

China Unveils Groundbreaking Policy for Innovative Drugs: What the New Commercial Insurance Catalog Means for Investors & Founders

China Finance Tech in ChinaChina healthcare, commercial insurance, drug policy, Hotgen Biotech, pharmaceutical innovation, RemeGen, Shatshn

July 1, 2025

FreshFromChina organizes publicly available and confirmed data. If you spot an error or have a better/great reference, please let us know:
📫 [email protected]

FreshFromChina is intended as an informational tool only. Content associated with FreshFromChina is not considered opinions or advice (financial or otherwise).

Get the Freshest from China, right to your inbox

Weekly updates on 📈 trends,
💻 tech, & 🧧 finance coming out of the Middle Kingdom.

⛩ oh and it’s free! ⛩

Name *

Email *

Please do not fill in this field.

Scroll to Top